Shanghai RAAS Blood Products Co Ltd - Class A

1
SZSE:002252 (China)   Class A
Â¥ 7.44 (-1.06%) May 10
26.86
P/B:
1.62
Market Cap:
Â¥ 49.44B ($ 6.84B)
Enterprise V:
Â¥ 44.52B ($ 6.16B)
Volume:
41.34M
Avg Vol (2M):
31.67M
Volume:
41.34M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Shanghai RAAS Blood Products Co Ltd ( SZSE:002252 ) from 2008 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shanghai RAAS Blood Products stock (SZSE:002252) PE ratio as of May 12 2024 is 26.86. More Details

Shanghai RAAS Blood Products Co Ltd (SZSE:002252) PE Ratio (TTM) Chart

To

Shanghai RAAS Blood Products Co Ltd (SZSE:002252) PE Ratio (TTM) Historical Data

Total 1181
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shanghai RAAS Blood Products PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-12 26.9 2024-03-04 27.1
2024-05-10 26.9 2024-03-01 26.9
2024-05-09 27.1 2024-02-29 26.7
2024-05-08 26.9 2024-02-28 26.1
2024-05-07 26.5 2024-02-27 26.4
2024-05-06 26.5 2024-02-26 26.1
2024-04-30 25.9 2024-02-23 26.2
2024-04-29 26.0 2024-02-22 26.3
2024-04-26 26.0 2024-02-21 26.0
2024-04-25 26.2 2024-02-20 26.0
2024-04-24 25.5 2024-02-19 25.8
2024-04-23 25.4 2024-02-08 25.5
2024-04-22 25.5 2024-02-07 25.3
2024-04-19 25.3 2024-02-06 24.8
2024-04-18 25.2 2024-02-05 23.0
2024-04-17 24.7 2024-02-02 23.2
2024-04-16 24.1 2024-02-01 23.9
2024-04-15 24.5 2024-01-31 23.8
2024-04-12 24.4 2024-01-30 24.3
2024-04-11 24.6 2024-01-29 25.0
2024-04-10 24.7 2024-01-26 25.3
2024-04-09 25.1 2024-01-25 25.4
2024-04-08 24.8 2024-01-24 24.8
2024-04-03 25.4 2024-01-23 24.6
2024-04-02 25.3 2024-01-22 24.6
2024-04-01 25.8 2024-01-19 25.6
2024-03-29 25.6 2024-01-18 25.8
2024-03-28 25.4 2024-01-17 25.9
2024-03-27 26.0 2024-01-16 26.5
2024-03-26 26.1 2024-01-15 26.5
2024-03-25 26.1 2024-01-12 26.7
2024-03-22 26.5 2024-01-11 27.2
2024-03-21 26.8 2024-01-10 27.4
2024-03-20 27.2 2024-01-09 28.2
2024-03-19 27.2 2024-01-08 27.8
2024-03-18 27.4 2024-01-05 28.9
2024-03-15 27.4 2024-01-04 29.0
2024-03-14 27.4 2024-01-03 28.9
2024-03-13 28.0 2024-01-02 28.3
2024-03-12 27.0 2023-12-29 29.6
2024-03-11 26.7 2023-12-28 29.4
2024-03-08 26.4 2023-12-27 26.2
2024-03-07 26.3 2023-12-26 26.0
2024-03-06 26.9 2023-12-25 26.0
2024-03-05 27.0 2023-12-22 26.0

Shanghai RAAS Blood Products Co Ltd (SZSE:002252) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Shanghai RAAS Blood Products Co Ltd is a blood products manufacturer in China that has high comprehensive utilization of plasma raw material and a range of products with different specifications. It is engaged in the research, development, and manufacture of blood products and plasma-derived medical products. The company's products include albumin, coagulation factors, and others.